Nick Leschly | Chief Executive Officer |
Elizabeth Pingpank | Direct Investor Relations |
Andrew Obenshain | President Severe Genetic Diseases |
Philip Gregory | Chief Scientific Officer |
William Denise Baird | Chief Financial Officer |
Salvesen Richter | Goldman Sachs |
Mani Foroohar | SVB |
Yaron Werber | Cowen |
Difei Yang | Mizuho Securities |
Charlie Ang | Morgan Stanley |
Dane Leone | Raymond James |
Gena Wang | Barclays |
Jason Gerberry | Bank of America |
Matthew Luchini | BMO Capital |
Mark Breidenbach | Oppenheimer |
Raju Prasad | William Blair |
Luca Issi | RBC |
Good day and thank you for standing by. Welcome to the Bluebird Bio Second Quarter 2021 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you will need to [Operator instructions].